Skip to main content

Sagility Ltd

Stage 2 · Advancing · week 2Setup 3.8 WatchWeak -0.2

As of 9 Oct 2026, Sagility is in Stage 2 — advancing, the uptrend phase, in week 2 (since 30 Sep 2026). It closed at ₹44, 19.3% below its 52-week high and above its 200-day average, which is falling. In Financials, 22.0% of stocks are in Stage 2.

Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. More about the company

₹44
+1.50% today
₹20,598 Cr · Large cap
Market Neutral — FadingFinancials 22.0% in Stage 2-11.7 pts / 20dSpecialized Finance 31.6%-5.3 pts

Pro read

Pro

Our read

Early entry — still early enough in its move

Setup score

3.8 Watch

Momentum

Steady

Edge

Weak -0.2

Setup-score rank among Stage 2 peers: #3 of 6 in Specialized Finance · #36 of 58 in Financials

Is SAGILITY early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
vs 52W High
-19.3%
₹36.4 lo₹54.5 hi
19.3% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 2
1w13w26w
Week 2 — fresh breakout, verify structure
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
0.1%
200 DMA: ₹43.9 · sloping down
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.78x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -3.1% vs MA50 +2.4%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-3.7%
3M
+3.5%
6M
+2.7%
YTD
-16.3%
1Y
+1.2%
Sector
Financials
↓ Peaking
Stage 2%
22.0%
20d Δ
-11.7pp
1M return
-4.1%
3M return
-6.7%
Sector Stage-2 % · last 20 days
This stock ranks #36 of 55 Stage 2 stocks in Financials by RS.
Industry
Specialized Finance
↓ Peaking
Stage 2%
31.6%
20d Δ
-5.3pp
1M return
-8.3%
3M return
-14.4%
Industry Stage-2 % · last 20 days
Ranks #5 of 6 Stage 2 stocks in this industry.
Stage Cycle Timeline2024-11-12 → 2026-10-09
S? 42w
S2 24w
S4 11w
2024-11-122026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S2 24w → S3 4w → S4 11w → S1 4w → S4 5w → S1 8w → S2 1w current
Total tracked: 100 weeks across 8 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-09-30
2 appearances in last 60 days. First seen: 2025-09-02.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S2
Wk 2 · Vol 0.78x
2026-10-08S2
Wk 2 · Vol 1.10x
2026-10-07S2
Wk 1 · Vol 0.36x
2026-10-06S2
Wk 1 · Vol 0.36x
2026-10-05S2
Wk 1 · Vol 0.77x
2026-10-01S2
Wk 1 · Vol 0.49x
2026-09-30S21→2
Wk 1 · Vol 0.48x
2026-09-29S1
Wk 8 · Vol 0.48x
2026-09-28S1
Wk 8 · Vol 0.33x
2026-09-25S1
Wk 7 · Vol 0.40x
2026-09-24S1
Wk 7 · Vol 0.45x
2026-09-23S1
Wk 7 · Vol 0.24x
Sector Peers — Stage 2All →
SMCGLOBAL
wk 10 · 0.0% from hi
9.4
GCSL
wk 15 · 0.0% from hi
8.4
ONELIFECAP
wk 1 · 0.0% from hi
8.2
ARIHANTCAP
wk 4 · -17.9% from hi
7.9
PAISALO
wk 26 · -13.4% from hi
7.5
Moving averages & range
50 DMA
₹44.3
200 DMA
₹43.9
52W High
₹54.5
52W Low
₹36.4
5D Low
₹42.6
Resistance levels (recent highs)
20d High
₹46
60d High
₹47.1
120d High
₹47.1
250d High
₹54.5
Next resistance
+4.5%
to 20d High
P/E (TTM)
20.9
Forward 14.3
Earnings Growth (YoY)
+23.9%
Revenue +35.7%
Dividend Yield
0.23%
P/B 2.2
About this companyFinancials· Specialized Finance

Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrative support provider, and data management services. It also provides utilization and care management, and population health management, as well as revenue cycle management functions, such as financial clearance, medical coding, billing, labs and durable medical equipment support, patient access and engagement, and accounts receivable follow-up services. In addition, it provides services to pharmacy benefit managers that manage prescription drugs for members under health insurance plans. Further, it offers various platforms, including document processing engine, genAI solutions for customer and member engagement, nurse assist, revenue cycle management, provider forward, enrolment and plan automation, and contract central. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. The company was incorporated in 2021 and is based in Bengaluru, India. Sagility Limited operates as a subsidiary of Sagility B.V.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.